Free technical and fundamental stock screener and chart pattern scanner for NSE, BSE, NASDAQ and NYSE
Stage
Not given
Not given
Founded
Not given
Not given
Based in
Not given
IN
Pricing model
Freemium
Freemium
Pricing
Free plan with 6 daily signals (4 per day drawn randomly: 1 per method in Europe and 2 in US), limited access; Starter €9.99/month with all signals, conviction scores, and 15 markets; Professional €24.99/month with full signal analysis and unlimited alerts. Both paid plans include a 7-day free trial
Free plan with 50 scans per day; Plus at ₹149/month (150 scans per day); Pro at ₹499/month (500 scans per day)
Key features
1,700 stocks analyzed daily across 15 global markets
Bounce strategy targeting +3% in ~10 sessions
Impulse strategy targeting +10% over weeks
Conviction Score from 0 to 100 for each signal
Machine learning model analyzing 21 technical indicators
Quality, Value, Technical and Dividend stock rankings
Portfolio tracking with alerts and exit notifications
Daily data updates after market close
Public record of all closed signals with win/loss history
Bull flag and bear flag pattern detection
Multi-timeframe chart structure analysis
EMA squeeze detection
Over 40 candle formations including hammers and engulfing patterns
Watchlist with auto-refresh
Fundamental analysis with forensic checks
Real-time corporate announcements
Portfolio health and trade audit
Broker connection for live prices
What makes it different
Public scoreboard tracking US Bounce signals with conviction 86+ against S&P 500
Free daily signals drawn randomly (not cherry-picked) viewable without account
All closed trades publicly archived with no look-ahead bias
Historical win rate and past trade count shown for each signal
Automatically reads charts across structure, patterns and formations in one scan unlike TradingView where you draw manually
Multi-timeframe confluence analysis with candle formation context unlike Chartink which screens for simple indicators
Free forever with no credit card required for the base plan
Coverage of 2000+ NSE stocks and US markets
Forensic analysis on 18+ checks including cash flow quality and dividend sustainability